{"id":"aca-continuation","safety":{"commonSideEffects":[{"rate":null,"effect":"Unknown"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ACA Continuation is a continuation of the ACA drug, which means it continues to provide the same effects as the original drug. This is done by maintaining the same mechanism of action, which is to continue the effects of the original drug.","oneSentence":"ACA Continuation works by continuing the effects of ACA.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T03:18:38.570Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Continuation of ACA treatment"}]},"trialDetails":[{"nctId":"NCT04963946","phase":"PHASE2","title":"STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"French Innovative Leukemia Organisation","startDate":"2021-10-18","conditions":"Untreated Chronic Lymphocytic Leukemia","enrollment":160}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ACA Continuation","genericName":"ACA Continuation","companyName":"French Innovative Leukemia Organisation","companyId":"french-innovative-leukemia-organisation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ACA Continuation works by continuing the effects of ACA. Used for Continuation of ACA treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}